| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 1,196 | $91.33 | $109,230.68 | -1.8% | -52.3% | -57.3% | |
| Dec 10, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 899 | $91.33 | $82,105.67 | -1.6% | -52.3% | -57.3% | |
| Dec 10, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 15,303 | $212.09 | $3,245,629.02 | -0.1% | -27.6% | +0.5% | |
| Dec 10, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 15,303 | $212.09 | $3,245,629.02 | -0.1% | -27.6% | +0.5% | |
| Dec 10, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 1,050 | $91.33 | $95,896.50 | -0.2% | -52.3% | -57.3% | |
| Dec 10, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,145 | $91.33 | $104,572.85 | -2.7% | -52.3% | -57.3% | |
| Dec 9, 2021 | RVTY Revvity, Inc. | Tereau Daniel R69 | Please See Remarks | Sell | 3,546 | $189.55 | $672,160.94 | -5.9% | -7.9% | -25.6% | |
| Dec 9, 2021 | CDNA Caredx, Inc. | Goldberg Michael85 | Director | Sell | 500 | $45.41 | $22,705.25 | -0.8% | -17.2% | -70.9% | |
| Dec 8, 2021 | TWST Twist Bioscience Corp | Leproust Emily M.77 | President &CEO | Sell | 6,960 | $85.52 | $595,245.74 | -1.4% | -47.4% | -70.8% | |
| Dec 8, 2021 | TWST Twist Bioscience Corp | Thorburn James M84 | Chief Financial Officer | Sell | 7,000 | $89.37 | $625,572.55 | -2.1% | -47.4% | -70.8% | |
| Dec 8, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 34,391 | $212.29 | $7,300,942.79 | -0.3% | -33.2% | -1.8% | |
| Dec 8, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 34,391 | $212.29 | $7,300,942.79 | -0.3% | -33.2% | -1.8% | |
| Dec 7, 2021 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 15,357 | $37.71 | $579,140.35 | -5.8% | -40.5% | -34.9% | |
| Dec 7, 2021 | NTRA Natera, Inc. | Schueren Robert Alan66 | Chief Operating Officer | Sell | 4,411 | $91.99 | $405,776.71 | -17.9% | -43.2% | -58.4% | |
| Dec 7, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 4,726 | $91.99 | $434,754.19 | -10.5% | -43.2% | -58.4% | |
| Dec 7, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 3,151 | $91.99 | $289,866.79 | -5.5% | -43.2% | -58.4% | |
| Dec 7, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,501 | $91.99 | $322,063.99 | -5.2% | -43.2% | -58.4% | |
| Dec 6, 2021 | NEO Neogenomics Inc | Mallon Mark | Chief Executive Officer | Buy | 17,000 | $30.63 | $520,710.00 | +30.5% | -43.0% | -63.4% | |
| Dec 6, 2021 | CDNA Caredx, Inc. | Maag Peter83 | Director | Sell | 10,000 | $41.62 | $416,189.87 | -1.0% | -25.3% | -69.3% | |
| Dec 6, 2021 | RDNT Radnet, Inc. | Hames Norman R56 | Pres And Coo-west Operations | Sell | 20,000 | $27.54 | $550,764.84 | -2.1% | -26.2% | -26.9% | |
| Dec 3, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | CEO | Sell | 400 | $211.48 | $84,592.00 | - | -27.9% | +1.4% | |
| Dec 3, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 400 | $211.48 | $84,592.00 | - | -27.9% | +1.4% | |
| Dec 2, 2021 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 620 | $83.16 | $51,557.96 | -0.5% | -29.5% | -56.7% | |
| Dec 2, 2021 | TWST Twist Bioscience Corp | Finn Patrick John73 | Chief Commercial Officer | Sell | 1,758 | $88.04 | $154,774.32 | -2.2% | -39.4% | -68.7% | |
| Dec 2, 2021 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer | Sell | 419 | $12.92 | $5,413.48 | -0.5% | -25.0% | -78.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.